NAFLD/NASH Medications
The NAFLD/NASH medications' page includes experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
*generic or biosimilar available
E experimental
| DRUG cenicriviroc |
|---|
|
|
| GENERIC NAME cenicriviroc |
| COMPANY Allergan |
| DRUG cilofexor |
|---|
|
|
| GENERIC NAME N/A |
| COMPANY Gilead Sciences |
| DRUG elafibranor |
|---|
|
|
| GENERIC NAME elafibranor |
| COMPANY Genfit |
| DRUG emricasan |
|---|
|
|
| GENERIC NAME emricasan |
| COMPANY Conatus |
| DRUG firsocostat |
|---|
|
|
| GENERIC NAME N/A |
| COMPANY Gilead Sciences |
| DRUG Ocaliva |
|---|
|
|
| GENERIC NAME obeticholic acid |
| COMPANY Intercept Pharmaceuticals |
| DRUG pegbelfermin |
|---|
|
|
| GENERIC NAME pegbelfermin |
| COMPANY Bristol-Myers Squibb |
| DRUG selonsertib |
|---|
|
|
| GENERIC NAME selonsertib |
| COMPANY Gilead Sciences |
| DRUG tropifexor |
|---|
|
|
| GENERIC NAME tropifexor |
| COMPANY Novartis |